WASHINGTON (AP) - An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies.
An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, S
WASHINGTON (AP) - An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies.
Please read our comment policy before commenting.